New Therapy Protocol For Colorectal Cancer – Over 50% Had Complete Response!

Precision Cancer Medicine specialist, Alex Rolland, discusses a recent study that is bringing hope to many patients with locally advanced colorectal cancer – by giving them a much higher chance at long-term remission.

Alex explains the exciting results of the TORCH study, which found that adding a combination of certain therapies prior to surgery made a massive difference to the numbers of colon cancer patients achieving remission.

Significantly, over 50% of patients who received this combination in the trials had something called a “Pathological Complete Response” – also known as pCR. This means there is no evidence of disease anywhere in the body!

More than that, patients who achieve a pCR with this neoadjuvant protocol can expect to be cancer-free for 10 years or more – for many, it means life-long remission. This is compared to only 15% of those who receive the current standard of care and have the same response.

While it is clear from the data that this new protocol should be the new standard of care for locally advanced mCRC, it is not yet standard of care in Canada.

So the question is → How can you tell if you are eligible for this new protocol and, if so, how can you access it from your current doctor?

Alex is joined by Precision Oncology Advocate and CTOAM cofounder, Michelle Morand. They also share next steps to take to find out if this new treatment protocol will work for you and how to access it.

Watch this video to find out!

00:00 Introduction
00:16 Alex’s Presentation: Neoadjuvant Immune Therapy For pMMR/MSS Locally Advanced Rectal Cancer
01:29 Issues with biomarkers in standard care – and how to get past them?
02:55 Colorectal cancer and immune therapy
03:49 What is the current standard of care for colorectal cancer?
04:54 Adding immune therapy to standard chemo / radiation
06:15 The importance of a pCR after neoadjuvant therapy
07:06 Exploring the recent TORCH study
09:53 Understanding the results of the TORCH study
10:44 Looking at the adverse events (side-effects)
11:16 Summary of these groundbreaking study results
18:25 How to get the information and support you need now?

Some useful terms 👇
▶ pCR = Pathological Complete Response
▶ Neoadjuvant = Prior to surgery
▶ Adjuvant = Post-surgery

Read more about the TORCH study: https://ascopubs.org/doi/10.1200/JCO....

More helpful videos👇
→ Understanding Cancer Treatment Studies:    • Understanding Oncology Statistics: Ho...  
→ Aspirin and Colon Cancer:    • Aspirin and Colon Cancer: How and Why...  

Don’t waste time on the wrong treatment - find out what is best for you and how to get your doctor to prescribe it. Get a Complete Treatment Options Review with specialist Alex Rolland and his team, book a Precision Second Opinion:
➡️ https://www.ctoam.com/consultation 🩺

***

Other ways to learn more about your cancer care options:

➡️ Book a free introductory call with Michelle to learn more about how precision cancer medicine works and how it may benefit you: https://www.ctoam.com/free-strategy-s...

➡️ Want to learn how to access the newest treatments through your current doctor?
Join our (free) online Self-Advocacy training program: https://help.ctoam.com/just-the-facts

Download CTOAM’S Free Ebook Here: https://www.ctoam.com/ebook/

-

CTOAM is a worldwide, Canadian-based personalized cancer care and precision oncology service specializing in getting our client's rapid access to the best possible cancer treatment available for their form of cancer, while assisting their physicians in having the most current data from which to make confident treatment decisions on your behalf.

We facilitate access to peer-reviewed, science-based precision diagnostics such as PET/CT scans, liquid biopsy (blood-based genetic tests) and detailed genetic panels. We use these leading diagnostic tools, combined with a thorough and personalized research review, as our team explores the most advanced scientific data available today to find the best options for you.

Other ways to stay in touch with CTOAM:

Facebook:   / cancertreatmentoptionsandmanagement  
LinkedIn:   / ctoam  
Twitter:   / ctoam  
Blog: https://research.ctoam.com/


LinkedIn (Liquid Biopsy Labs):   / 13063544  
LBL Twitter:   / liquidbiopsynow  


Disclaimer:

Please understand that these videos are meant for educational purposes only. These videos are not intended to diagnose or be used as treatment advice. Viewers are encouraged to speak with their doctor or healthcare professionals for medical advice and before making any changes to their healthcare based on this information. All statements made in this video regarding medical treatments and health conditions are sourced and have been approved by the U.S. Food and Drug Administration (FDA). Watching this video is not a substitute for professional medical advice or a diagnosis.